GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,462,000 | +264.6% | 12,672 | +207.1% | 0.00% | +100.0% |
Q3 2020 | $401,000 | +3241.7% | 4,127 | +4027.0% | 0.00% | – |
Q2 2020 | $12,000 | -96.4% | 100 | -97.3% | 0.00% | -100.0% |
Q1 2020 | $330,000 | -57.8% | 3,772 | -49.6% | 0.00% | -50.0% |
Q4 2019 | $782,000 | -52.4% | 7,484 | -47.7% | 0.00% | -60.0% |
Q3 2019 | $1,644,000 | +423.6% | 14,300 | +666.3% | 0.01% | +400.0% |
Q1 2019 | $314,000 | -14.0% | 1,866 | -50.3% | 0.00% | 0.0% |
Q4 2018 | $365,000 | -91.3% | 3,756 | -84.5% | 0.00% | -92.3% |
Q3 2018 | $4,196,000 | +201.9% | 24,291 | +143.8% | 0.01% | +160.0% |
Q2 2018 | $1,390,000 | +13.0% | 9,965 | +6.9% | 0.01% | -90.6% |
Q4 2017 | $1,230,000 | -4.2% | 9,324 | -26.3% | 0.05% | +1.9% |
Q3 2017 | $1,284,000 | +110.8% | 12,659 | +132.0% | 0.05% | +44.4% |
Q4 2016 | $609,000 | +21.1% | 5,456 | -0.7% | 0.04% | +5.9% |
Q2 2016 | $503,000 | +570.7% | 5,494 | +403.1% | 0.03% | +466.7% |
Q4 2015 | $75,000 | -77.1% | 1,092 | -69.6% | 0.01% | -84.2% |
Q1 2015 | $327,000 | – | 3,589 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |